menu
    • menu

    Company profile for Rani Therapeutics

    NEW Drugs in Dev: 10
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The concept for Rani was developed by Mir Imran, a prolific medical inventor and entrepreneur who has founded more than twenty life sciences companies. Rani was established as a company in 2012 after several years as a research project within InCube Labs, Mir’s multi-disciplinary life sciences lab focused on developing and commercializing breakthrough innovations. Our mission is to improve the lives of millions of patients ...
    The concept for Rani was developed by Mir Imran, a prolific medical inventor and entrepreneur who has founded more than twenty life sciences companies. Rani was established as a company in 2012 after several years as a research project within InCube Labs, Mir’s multi-disciplinary life sciences lab focused on developing and commercializing breakthrough innovations. Our mission is to improve the lives of millions of patients suffering from chronic conditions by replacing painful injections with an easy and pain free pill.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Rani TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2051 Ringwood Ave. San Jose CA, 95131
    Telephone
    Telephone
    408-457-3700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ranitherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rani Pharma Joins H.C. Wainwright Bioconnect Conference
    Rani Pharma Joins H.C. Wainwright Bioconnect Conference

    12 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/12/3293393/0/en/rani-therapeutics-to-participate-in-the-h-c-wainwright-annual-bioconnect-investor-conference.html

    GLOBENEWSWIRE
    12 May 2026
    Share Share
    Rani Therapeutics Names Dr. Sara Kenkare-Mitra as Advisor
    Rani Therapeutics Names Dr. Sara Kenkare-Mitra as Advisor

    09 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/09/3270784/0/en/Rani-Therapeutics-Appoints-Dr-Sara-Kenkare-Mitra-as-Strategic-Advisor-to-Advance-Platform-and-Clinical-Strategy.html

    GLOBENEWSWIRE
    09 Apr 2026
    Share Share
    Rani Therapeutics's 2025 Financial Results And Corporate Update
    Rani Therapeutics's 2025 Financial Results And Corporate Update

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3263414/0/en/Rani-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share
    Rani Therapeutics Appoints Jesper Høiland To Lead Strategy
    Rani Therapeutics Appoints Jesper Høiland To Lead Strategy

    25 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/25/3262623/0/en/Rani-Therapeutics-Appoints-Jesper-H%C3%B8iland-as-Head-of-Strategy-to-Advance-Corporate-and-Pipeline-Prioritization.html

    GLOBENEWSWIRE
    25 Mar 2026
    Share Share
    Rani Therapeutics To Release 2025 Full-Year Financial Results
    Rani Therapeutics To Release 2025 Full-Year Financial Results

    19 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/19/3259426/0/en/Rani-Therapeutics-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    19 Mar 2026
    Share Share
    Rani Announces Promotion of Alireza to Chief Technical Officer
    Rani Announces Promotion of Alireza to Chief Technical Officer

    28 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/28/3227454/0/en/Rani-Therapeutics-Announces-the-Promotion-of-Alireza-Javadi-Ph-D-to-Chief-Technical-Officer.html

    GLOBENEWSWIRE
    28 Jan 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search